The study did not reveal mutations in NPHS1 and WT1. Therefore, target-oriented next generation sequencing analysis of glomerulopathy-related panel of genes is recommended to search for mutations in other genes related to SRNS. The gene discussed is NPHS1; the disease is lipoprotein glomerulopathy.